1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow belumosudil: new trials by email Literature Review of belumosudil trials Research Report on belumosudil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease Belumosudil, Best available therapy (BAT) - Chronic Graft Versus Host Disease | Phase 3 | Not yet recruiting | Sanofi | 356 | 2026-09-07 | 2026-09-15 |
| A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. Belumosudil, Placebo, Prednisone - Chronic Graft Versus Host Disease | Phase 3 | Active not recruiting | Sanofi | 260 | 2024-01-23 | 2026-10-16 |
| A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction Belumosudil, Azithromycin, Placebo - Lung Transplant Rejection | Phase 3 | Recruiting | Sanofi | 180 | 2023-10-10 | 2026-10-28 |
Bronchiolitis Obliterans Syndrome (2)
Sanofi (3)
Australia (2) · Austria (2) · Belgium (2) · Canada (2) · China (2) · Czechia (2) · Denmark (2) · France (2) · Germany (2) · Israel (2) · Italy (2) · Netherlands (2) · South Korea (2) · Spain (2) · Sweden (2)
2023 (2)